Treatment News : Starting HIV Meds When CD4s Are Low Raises Cancer Risk

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » June 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


June 12, 2013

Starting HIV Meds When CD4s Are Low Raises Cancer Risk

With cancer an increasingly significant cause of sickness and death among people with HIV, a new study has shed important light on the timing and patterns of cancer diagnoses after antiretroviral (ARV) treatment is begun, aidsmap reports. Reporting their findings in the online edition of Clinical Infectious Diseases, a team of researchers analyzed records of 11,485 people with HIV who began ARVs between 1996 and 2011, with a median year of 2004. As the study population began therapy, the median CD4 count was 202.

The incidence rates for Kaposi’s sarcoma (KS) and for lymphomas were at their peak in the six months following ARV initiation; after that, they leveled off. On average, incidence rates for all other cancers combined increased at an average of 7 percent each year between one and 10 years after beginning ARVs—a finding the study authors attributed to the effects of aging. Having a lower CD4 count when starting therapy was associated with a greater risk of KS, lymphoma and human papillomavirus (HPV)–related cancer.

To read the aidsmap story, click here.

To read the study abstract, click here.

Search: HIV, antiretrovirals, CD4 count, cancer, Kaposi's sarcoma, lymphoma, Clinical Infectious Diseases.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.